DE69033143D1 - Cytokinsynthesehemmender faktor (csif) und verfahren zur anwendung - Google Patents
Cytokinsynthesehemmender faktor (csif) und verfahren zur anwendungInfo
- Publication number
- DE69033143D1 DE69033143D1 DE69033143T DE69033143T DE69033143D1 DE 69033143 D1 DE69033143 D1 DE 69033143D1 DE 69033143 T DE69033143 T DE 69033143T DE 69033143 T DE69033143 T DE 69033143T DE 69033143 D1 DE69033143 D1 DE 69033143D1
- Authority
- DE
- Germany
- Prior art keywords
- synthesis
- csif
- cytokin
- application
- inhibiting factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37266789A | 1989-06-28 | 1989-06-28 | |
US45395189A | 1989-12-20 | 1989-12-20 | |
PCT/US1990/003554 WO1991000349A1 (en) | 1989-06-28 | 1990-06-28 | Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69033143D1 true DE69033143D1 (de) | 1999-07-08 |
DE69033143T2 DE69033143T2 (de) | 1999-10-21 |
Family
ID=27005854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69033143T Expired - Lifetime DE69033143T2 (de) | 1989-06-28 | 1990-06-28 | Cytokinsynthesehemmender faktor (csif) und verfahren zur anwendung |
Country Status (22)
Country | Link |
---|---|
EP (2) | EP0567450B1 (de) |
JP (1) | JP2813063B2 (de) |
KR (1) | KR0183035B1 (de) |
CN (3) | CN1318589C (de) |
AT (1) | ATE180833T1 (de) |
AU (1) | AU635058B2 (de) |
CA (1) | CA2062763C (de) |
CS (1) | CS414591A3 (de) |
DE (1) | DE69033143T2 (de) |
DK (1) | DK0567450T3 (de) |
ES (1) | ES2132068T3 (de) |
FI (1) | FI107926B (de) |
GR (1) | GR3030404T3 (de) |
HK (3) | HK1008834A1 (de) |
HU (1) | HU216310B (de) |
IL (1) | IL94878A (de) |
NO (1) | NO301718B1 (de) |
NZ (1) | NZ234291A (de) |
PT (1) | PT94514B (de) |
SG (1) | SG52282A1 (de) |
TW (1) | TW218383B (de) |
WO (1) | WO1991000349A1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5827513A (en) * | 1990-06-29 | 1998-10-27 | Schering Corporation | Methods of treating insulin-dependent diabetes mellitus by administration of IL-10 |
DE69203443T2 (de) * | 1991-01-16 | 1995-12-07 | Schering Corp | Verwendung von interleukin-10 in der adoptive immunotherapie von krebs. |
SK279556B6 (sk) * | 1991-01-16 | 1998-12-02 | Schering Corporation | Liečivo na liečenie nádorov pacienta |
US6106823A (en) * | 1991-01-16 | 2000-08-22 | Schering Corporation | Treatment of neoplastic disease with interleukin-10 |
DE4122402A1 (de) * | 1991-07-04 | 1993-01-07 | Schering Ag | Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit |
US5833976A (en) * | 1991-08-06 | 1998-11-10 | Schering Corporation | Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity |
DK0600970T3 (da) * | 1991-08-06 | 2000-05-29 | Schering Corp | Anvendelse af interleukin-10-analoger eller -antagonister til behandling af endotoksin- eller superantigeninduceret tokscit |
US6277635B1 (en) | 1992-03-04 | 2001-08-21 | Schering Corporation | Use of interleukin-10 to produce a population of suppressor cells |
EP0629130A1 (de) * | 1992-03-04 | 1994-12-21 | Schering Corporation | Verwendung von interleukin-10 zur unterdrückung der graft versus host krankheit |
US6884410B1 (en) | 1992-03-04 | 2005-04-26 | Schering Corporation | Methods for modulating antigen-specific immune responses |
AU3801193A (en) * | 1992-03-20 | 1993-10-21 | Schering Corporation | Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
HU220103B (hu) * | 1992-08-20 | 2001-10-28 | Schering-Plough Corp. | IL-10 új alkalmazása |
US5601815A (en) * | 1992-08-21 | 1997-02-11 | Schering Corp | IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells |
JPH08501549A (ja) * | 1992-09-18 | 1996-02-20 | スケアリング コーポレイション | Hiv感染された患者におけるtヘルパー細胞の免疫担当能力の回復 |
EP0662837B1 (de) * | 1992-10-01 | 1999-05-19 | Schering Corporation | Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus |
TW381026B (en) * | 1993-01-13 | 2000-02-01 | Schering Corp | Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells |
WO1994017773A2 (en) * | 1993-02-01 | 1994-08-18 | Université Libre de Bruxelles | Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
US5328989A (en) * | 1993-03-05 | 1994-07-12 | Schering-Plough | Purification of human interleukin-10 from a cell culture medium |
US5449688A (en) * | 1993-03-30 | 1995-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating chronic inflammatory diseases |
CZ23396A3 (en) * | 1993-07-26 | 1996-05-15 | Schering Corp | Antagonists and agonists of human interleukin-10 |
US5650060A (en) * | 1994-01-28 | 1997-07-22 | Minnesota Mining And Manufacturing Company | Ionically conductive agent, system for cathodic protection of galvanically active metals, and method and apparatus for using same |
AP690A (en) * | 1994-07-05 | 1998-10-16 | Steeno Res Group A/S | Immunomodulators based on a polypeptide other than human interleukin 10. |
US5770190A (en) * | 1995-07-14 | 1998-06-23 | Schering Corporation | Method of treatment of acute leukemia with inteleukin-10 |
CN100389126C (zh) * | 1995-12-13 | 2008-05-21 | 儿童医学中心公司 | 内皮细胞增殖抑制剂及其应用方法 |
AU4385696A (en) * | 1996-01-18 | 1997-08-11 | Christian Gronhoj Larsen | Synthetic il-10 analogues |
WO1997038695A1 (en) * | 1996-04-17 | 1997-10-23 | Prendergast Patrick T | Dhea combination therapy |
AU722570B2 (en) * | 1996-09-06 | 2000-08-03 | Schering Corporation | Method for lowering cholesterol levels |
AU5221998A (en) * | 1997-04-17 | 1998-11-13 | Patrick T. Prendergast | Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors |
US6465176B1 (en) * | 1998-10-02 | 2002-10-15 | Message Pharmaceuticals, Inc. | Method for identifying compounds RNA/RNA binding protein interactions |
AU5047600A (en) * | 1999-05-27 | 2000-12-18 | Schering Corporation | Mammalian interleukin-10 homologs: il-d110 and il-d210 |
KR20020091170A (ko) | 2000-03-31 | 2002-12-05 | 아이덱 파마슈티칼즈 코포레이션 | B 세포 림프종의 치료를 위한 항-사이토카인 항체 또는길항제 및 항-cd20의 조합된 사용 |
WO2011159881A2 (en) | 2010-06-16 | 2011-12-22 | Allergan, Inc. | Il-10 and methods of treating ocular and other diseases |
WO2017160599A1 (en) | 2016-03-14 | 2017-09-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of cd300b antagonists to treat sepsis and septic shock |
WO2018106959A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
WO2018183931A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist |
WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
US11707610B2 (en) | 2019-12-13 | 2023-07-25 | Biora Therapeutics, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
GB202003428D0 (en) * | 2020-03-10 | 2020-04-22 | Univ Dundee | IL-10 mutiens |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL78197A (en) * | 1985-03-22 | 1991-07-18 | Genentech Inc | Nucleic acid encoding tgf-beta and its uses |
IE62650B1 (en) * | 1989-08-04 | 1995-02-22 | David & Sons Ltd | Dispensing apparatus |
ES2064082T3 (es) * | 1989-12-20 | 1995-01-16 | Schering Corp | Proteinas bcrf1 como inhibidores de interferon-gamma. |
-
1990
- 1990-06-26 IL IL9487890A patent/IL94878A/xx active IP Right Grant
- 1990-06-27 CN CNB011124067A patent/CN1318589C/zh not_active Expired - Lifetime
- 1990-06-27 PT PT94514A patent/PT94514B/pt not_active IP Right Cessation
- 1990-06-27 CN CN90106678A patent/CN1051393A/zh active Pending
- 1990-06-28 DE DE69033143T patent/DE69033143T2/de not_active Expired - Lifetime
- 1990-06-28 DK DK90911213T patent/DK0567450T3/da active
- 1990-06-28 CA CA002062763A patent/CA2062763C/en not_active Expired - Lifetime
- 1990-06-28 TW TW079105311A patent/TW218383B/zh active
- 1990-06-28 NZ NZ234291A patent/NZ234291A/en unknown
- 1990-06-28 SG SG1996001964A patent/SG52282A1/en unknown
- 1990-06-28 EP EP90911213A patent/EP0567450B1/de not_active Expired - Lifetime
- 1990-06-28 EP EP90307091A patent/EP0405980A1/de active Pending
- 1990-06-28 WO PCT/US1990/003554 patent/WO1991000349A1/en active IP Right Grant
- 1990-06-28 AT AT90911213T patent/ATE180833T1/de not_active IP Right Cessation
- 1990-06-28 JP JP2510725A patent/JP2813063B2/ja not_active Expired - Lifetime
- 1990-06-28 HU HU906705A patent/HU216310B/hu unknown
- 1990-06-28 AU AU60770/90A patent/AU635058B2/en not_active Expired
- 1990-06-28 ES ES90911213T patent/ES2132068T3/es not_active Expired - Lifetime
- 1990-06-28 KR KR1019910700236A patent/KR0183035B1/ko active IP Right Grant
-
1991
- 1991-12-27 NO NO915115A patent/NO301718B1/no not_active IP Right Cessation
- 1991-12-27 FI FI916126A patent/FI107926B/fi active
- 1991-12-30 CS CS914145A patent/CS414591A3/cs unknown
-
1998
- 1998-07-29 HK HK98109520A patent/HK1008834A1/xx not_active IP Right Cessation
-
1999
- 1999-06-03 GR GR990401398T patent/GR3030404T3/el unknown
-
2001
- 2001-03-29 CN CNB011124059A patent/CN1198642C/zh not_active Expired - Lifetime
-
2002
- 2002-03-13 HK HK02101932.7A patent/HK1040493B/zh not_active IP Right Cessation
- 2002-03-13 HK HK02101934.5A patent/HK1040531B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69033143D1 (de) | Cytokinsynthesehemmender faktor (csif) und verfahren zur anwendung | |
ES8602768A1 (es) | Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas. | |
DK66692A (da) | En mammal cytokin, il-11 | |
FI935585A0 (fi) | Pyrrolopyrimidiner | |
NO965621D0 (no) | Nye hIL-4-mutantproteiner som antagonister eller partielle agonister for det humane interleukin 4 | |
PT91750A (pt) | Processo para a preparacao de factor de crescimento de celulas t auxiliares | |
NO922456D0 (no) | Bcrf1-proteiner som inhibitorer av interferon-gamma | |
DE68915694D1 (de) | Verfahren zur Herstellung von verzweigten 1,3-Glykolen und ihren Monoestern. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |